La clorexidina nella terapia parodontale.

Chlorhexidine a cationic antiseptic active against a wide spectrum of bacteria is widely and successfully used in the treatment of periodontal disease in the home and the outpatients' clinic. A review of the literature forms the basis for an assessment of the advantages and disadvantages of the various supra and subgingival application techniques with details of the limitations and risk/benefit ratio implicit in the various clinical situations

The efficacy of mineralized allograft cortical and cancellous chips in maxillary sinus augmentation

A mixture of mineralized allograft cortical and cancellous chips was used to augment the maxillary sinuses of 10 patients. Eleven sinus augmentation procedures were performed, and 19 bone cores were obtained at reentry after 6 to 7 months. Computed tomography at 6 months postaugmentation demonstrated bone formation in all sites. Light microscopic and histomorphometric evaluation confirmed bone formation at the treatment site that would receive osseointegrated implants to replace the missing maxillary posterior teeth. These encouraging results support the use of a mixture of mineralized allograft cortical and cancellous chips for sinus augmentation

Interventions for Dental Implant Placement in Atrophic Edentulous Mandibles: Vertical Bone Augmentation and Alternative Treatments. A Meta-Analysis of Randomized Clinical Trials

BACKGROUND The purpose was to assess which vertical bone augmentation technique is most effective for restoring atrophic posterior areas of the mandible with dental implants, and compare these procedures with alternative treatments. METHODS Electronic literature searches in PubMed (MEDLINE), Ovid and The Cochrane Library were conducted to identify all relevant articles published up to July 1st 2015. Eligibility was based on inclusion criteria, and quality assessments were conducted. The primary outcome variables were implant and prosthetic failure. After data extraction, meta-analyses were performed. RESULTS Out of 527 potentially eligible papers, 14 randomized clinical trials were included. Out of these 14 studies, 4 trials assessed short implants (5 to 8 mm) as an alternative to vertical bone augmentation in sites with a residual ridge height of 5 to 8 mm. No statistically significant differences were found in implant (OR: 1.02; 95%CI: 0.31 to 3.31; p=0.98; I(2): 0%) or prosthetic failure (OR: 0.64; 95%CI: 0.21 to 1.96; p=0.43; I(2): 0%) after 12 months of loading. However, complications at treated sites increased with the augmentation procedures (OR: 8.33; 95%CI: 3.85 to 20.0; p<0.001; I(2): 0%). There was no evidence of any vertical augmentation procedure being of greater benefit than any other for the primary outcomes (implant and prosthetic failure). CONCLUSION Short implants in the posterior area of the mandible seem to be preferable to vertical augmentation procedures, which present similar implant and prosthetic failure rates but greater morbidity. All the vertical augmentation technique comparisons showed similar inter-group results